IBT Staff Reporter

81601-81630 (out of 154943)

Sanofi talks may value Genzyme at $77/share: report

France's Sanofi-Aventis may raise its bid for U.S. biotech Genzyme Corp to about $76 or $77 per share, including a potential future payout based on the performance of an experimental drug, Bloomberg reported on Tuesday.

Carmakers start 2011 strongly

Carmakers are making a strong start to 2011, soothing concerns about slower demand growth in the Asian markets that drove sales last year and a bumpy recovery in western markets.

When and How Gold Will Begin its Bubble

The bull market in Gold is in its 12th year (globally it began in 1999) but has yet to exhibit any bubble-like conditions. Institutional accumulation began in 2009 (e.g. Paulson, Einhorn) and we know that phase lasts at least a few years before a bull market gives birth to a bubble.

Wall Street rises on solid manufacturing data

Stocks rose on Tuesday as solid manufacturing data in the United States and Europe helped investors turn their attention away from the turmoil in the Middle East to hopes that a global economic recovery was on track.

Energizer sees weak year, shares plunge 14 percent

Energizer Holdings Inc posted weaker-than-expected quarterly profit, weighed down by heavy spending to promote its new Schick Hydro razor, and offered a bleak full-year outlook, sending its shares down 14 percent in premarket trading.

Midwest set for Big Blizzard (City Reports)

A Major blizzard is expected to hit at least nine Midwest and plain states on Tuesday and Wednesday with a potential of one to two feet of snow, National Weather Service reports.

Wall Street to open higher on hopes for economy

Stocks were poised for a higher open on Tuesday as solid manufacturing data in Europe helped investors refocus attentions from the maelstrom in the Middle East to hopes that a global economic recovery was on track.

When Gold Bullion Fails

Whatever your finance advisor, economics professor, banker or coin dealer might tell you, no single asset class - bought today - can promise to hold or grow its value, year after year, until precisely the day when you need to sell it and spend.

Below-par BP earnings reignite growth worries

BP reignited doubts about its ability to return to growth on Tuesday as below-forecast profit, disappointing production guidance and new oil spill charges overshadowed the oil major's return to dividend payouts.

Pages